DK1573337T3 - Fremgangsmåde til påvisning af PrP ved anvendelse af en makrocyclisk hjælpeligand - Google Patents

Fremgangsmåde til påvisning af PrP ved anvendelse af en makrocyclisk hjælpeligand

Info

Publication number
DK1573337T3
DK1573337T3 DK03799682T DK03799682T DK1573337T3 DK 1573337 T3 DK1573337 T3 DK 1573337T3 DK 03799682 T DK03799682 T DK 03799682T DK 03799682 T DK03799682 T DK 03799682T DK 1573337 T3 DK1573337 T3 DK 1573337T3
Authority
DK
Denmark
Prior art keywords
macrocyclic
prpsc
auxiliary ligand
detecting prp
immunodetection
Prior art date
Application number
DK03799682T
Other languages
English (en)
Inventor
Aly Moussa
Anthony William Coleman
Patrick Shahgaldian
Silva Eric Da
Ambroise Martin
Adina Nicoleta Lazar
Edwige Leclere
Marilyne Dupin
Herve Perron
Original Assignee
Afssa
Centre Nat Rech Scient
Univ Claude Bernard Lyon
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afssa, Centre Nat Rech Scient, Univ Claude Bernard Lyon, Biomerieux Sa filed Critical Afssa
Application granted granted Critical
Publication of DK1573337T3 publication Critical patent/DK1573337T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
DK03799682T 2002-12-20 2003-12-19 Fremgangsmåde til påvisning af PrP ved anvendelse af en makrocyclisk hjælpeligand DK1573337T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0216383A FR2849205B1 (fr) 2002-12-20 2002-12-20 Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification
PCT/FR2003/003857 WO2004059322A1 (fr) 2002-12-20 2003-12-19 Procede de detection de la prp utilisant un ligand adjuvant macrocyclique.

Publications (1)

Publication Number Publication Date
DK1573337T3 true DK1573337T3 (da) 2007-06-11

Family

ID=32406305

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03799682T DK1573337T3 (da) 2002-12-20 2003-12-19 Fremgangsmåde til påvisning af PrP ved anvendelse af en makrocyclisk hjælpeligand

Country Status (14)

Country Link
US (2) US7217530B2 (da)
EP (1) EP1573337B1 (da)
JP (1) JP2006510914A (da)
CN (1) CN100380125C (da)
AT (1) ATE354095T1 (da)
AU (1) AU2003299390B2 (da)
BR (1) BR0317080A (da)
DE (1) DE60311871T2 (da)
DK (1) DK1573337T3 (da)
ES (1) ES2282733T3 (da)
FR (1) FR2849205B1 (da)
MX (1) MXPA05006766A (da)
PT (1) PT1573337E (da)
WO (1) WO2004059322A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2849205B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
FR2865279A1 (fr) * 2004-01-20 2005-07-22 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
FR2888937B1 (fr) 2005-07-21 2012-10-26 Biomerieux Sa Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes
US8722342B2 (en) * 2008-07-04 2014-05-13 Sekisui Medical Co., Ltd. Method for enhancing sensitivity or method for avoiding influence of hemoglobin in immunological measurement
WO2013091074A1 (en) * 2011-12-21 2013-06-27 Uvic Industry Partnerships Inc. Method and array for identifying histone-code-related analytes
US10338037B2 (en) 2015-08-18 2019-07-02 Uvic Industry Partnerships Inc. Compounds and conjugates for identifying and separating post-translationally modified analytes
CA3084887A1 (en) 2019-06-25 2020-12-25 Uvic Industry Partnerships Inc. Compound and dimer complex embodiments for supramolecular sensing
CN113876760B (zh) * 2021-10-26 2022-12-23 南开大学 杯芳烃和/或杯芳烃的衍生物在制备治疗创伤性脑损伤的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
US5342934A (en) * 1992-06-19 1994-08-30 The Trustees Of Columbia University In The City Of New York Enantioselective receptor for amino acid derivatives, and other compounds
EP0891364A1 (en) * 1996-04-05 1999-01-20 The Board Of Regents, The University Of Texas System Calixpyrroles, calixpyridinopyrroles and calixpyridines
US6054114A (en) * 1996-05-08 2000-04-25 Massachusetts Institute Of Technology Organometallic ligands for the localization and quantification of amyloid in vivo and in vitro
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein
EP1216258A1 (en) * 1999-09-28 2002-06-26 Universität Zürich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
EP1272509A2 (en) * 2000-04-05 2003-01-08 V.I. Technologies, Inc. Prion-binding peptidic ligands and methods of using same
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
DE10119713A1 (de) * 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
FR2849205B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification

Also Published As

Publication number Publication date
DE60311871T2 (de) 2007-10-31
MXPA05006766A (es) 2006-02-17
CN1729397A (zh) 2006-02-01
PT1573337E (pt) 2007-05-31
US7217530B2 (en) 2007-05-15
AU2003299390B2 (en) 2007-11-01
ES2282733T3 (es) 2007-10-16
BR0317080A (pt) 2005-10-25
AU2003299390A1 (en) 2004-07-22
EP1573337B1 (fr) 2007-02-14
US20070154885A1 (en) 2007-07-05
ATE354095T1 (de) 2007-03-15
WO2004059322A8 (fr) 2005-07-14
FR2849205A1 (fr) 2004-06-25
CN100380125C (zh) 2008-04-09
US20060019311A1 (en) 2006-01-26
JP2006510914A (ja) 2006-03-30
AU2003299390A8 (en) 2004-07-22
DE60311871D1 (de) 2007-03-29
FR2849205B1 (fr) 2005-02-11
EP1573337A1 (fr) 2005-09-14
WO2004059322A1 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
DK1573337T3 (da) Fremgangsmåde til påvisning af PrP ved anvendelse af en makrocyclisk hjælpeligand
DK2185937T4 (da) Fremgangsmåde til at bestemme sepsis hos mennesker
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
JOP20200216A1 (ar) تجارب للكشف عن التنكس العصبي
CL2011000010A1 (es) Anticuerpo monoclonal anti-peptido beta-amiloide; polinucleotido que lo codifica; hibridoma; metodo de produccion; composicion que lo comprende; uso para tratar enfermedades relacionadas con proteinas amiloides; metodo de diagnostico de las mismas; y kit que lo comprende.
ES2372709T3 (es) Procedimientos de cribado de proteasas y proteasas identificadas por los mismos.
MX337569B (es) Ligandos de proteina prion y metodos de uso.
ATE529752T1 (de) Antikörperquantifizierung
SI1745464T1 (sl) Priprava in postopek za analiziranje informacijskega signala
Voshol et al. Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection
ATE431558T1 (de) Morbus alzheimer-spezifische veränderungen des erk1/erk2-phosphorylierungsverhältnisses - morbus alzheimer-spezifische molekulare biomarker (adsmb)
EP1924710A4 (en) METHOD FOR DIAGNOSIS OF AN OVARIAN CARCINOMA AND KIT THEREFOR
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
ATE422673T1 (de) Test für übertragbare spongiforme encephalopathien
DK1386160T3 (da) Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse
WO2004007555A3 (en) Detection of prion disease
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
RU2010125235A (ru) Связывающее вещество патологического прионного белка и способ обнаружения патологического прионного белка
FI20040205A7 (fi) Menetelmä ja laite pikatestin valmistamiseksi
WO2007060373A3 (fr) Procede d'identification du genotype en position 171 de la proteine prion d'ovin ainsi que trousses de mise en oeuvre de ce procede
ATE438100T1 (de) Verfahren zum funktionellen nachweis von masps und dessen komplexen
ATE398288T1 (de) Hoch-durchsatz prion tests
DK1173764T3 (da) Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12
ATE481500T1 (de) Endotoxinanalyse